Together, these results indicated that miR-34a-5p inhibition can enhance the malignant properties of HNSCC cells, while simultaneous FLOT-2 knockdown was sufficient to partially reverse these oncogenic effects, consistent with a direct regulatory relationship between these two molecules in tumor cells. This evidence concerns the gene FLOT2 and head and neck squamous cell carcinoma.